Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease

Clinical Endocrinology

Volumn 52, Issue 6, 2000, Pages 775-780

  Gebre Medhin, Gennet ^a   Husebye, Eystein S ^a   Mallmin, Hans ^a   Helström, Lotti ^a   Berne, Christian ^a   Karlsson, F Anders ^a   Kämpe, Olle ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PRASTERONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

ACNE; ADDISON DISEASE; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERHIDROSIS; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PRURITUS;

ADDISON DISEASE; ADMINISTRATION, ORAL; ADULT; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DRUG ADMINISTRATION SCHEDULE; EVALUATION STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; TESTOSTERONE;

EID: 0034049759     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01017.x     Document Type: Article

References (21)

1. Arlt, W., Justl, H.G., Callies, F., Reincke, M., Hubler, D., Oettel, M., Ernst, M., Schulte, H.M. & Allolio, B. (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and oestrogens in young healthy females after dexamethasone suppression. Journal of Clinical Endocrinology and Metabolism, 83, 1928-1934.
2. Berr, C., Lafont, S., Debuire, B., Dartigues, J.F. & Baulieu, E.E. (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proceedings of the National Academy of Sciences of the USA, 93, 13410-13415.
3. Buffington, C.K., Pourmotabbed, G. & Kitabchi, A.E. (1993) Case report: amelioration of insulin resistance in diabetes with dehydroepiandrosterone. American Journal of Medicine Science, 306, 320-324.
4. Carlström, K., Brody, S., Lunell, N.O., Lagrelius, A., Möllerström, G., Pousette, A., Rannevik, G., Stege, R. & von Schoultz, B. (1988) Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas, 10, 297-306.
5. Daynes, R.A., Dudley, D.J. & Araneo, B.A. (1990) Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. European Journal of Immunology, 20, 793-802.
6. DeFronzo, R.A., Tobin, J.D. & Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223.
7. Devogelaer, J.P., Crabbe, J. & Nagant de Deuxchaisnes, C. (1987) Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. British Medical Journal, 294, 798-800.
8. Florkowski, C.M., Holmes, S.J., Elliot, J.R., Donald, R.A. & Espiner, E.A. (1994) Bone mineral density is reduced in female but not male subjects with Addison's disease. New Zealand Medical Journal, 107, 52-53.
9. Groves, R.W., Toms, G.C., Houghton, B.J. & Monson, J.P. (1988) Corticosteroid replacement therapy: twice or thrice daily? Journal of the Royal Society of Medicine, 81, 514-516.
10. Labrie, F., Diamond, P., Cusan, L., Gomez, J.L., Belanger, A. & Candas, B. (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in post-menopausal women. Journal of Clinical Endocrinology and Metabolism, 82, 3498-3505.
11. Longcope, C. (1996) Dehydroepiandrosterone metabolism. Journal of Endocrinology, 150 (Suppl.):S125-7.
12. Morales, A.J., Nolan, J.J., Nelson, J.C. & Yen, S.S. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published erratum appears Journal of Clinical Endocrinology and Metabolism, 80, 2799]. Journal of Clinical Endocrinology and Metabolism, 78, 1360-1367.
13. Mortola, J.F. & Yen, S.S. (1990) The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 71, 696-704.
14. Orentreích, N., Brind, J.L., Rizer, R.L. & Vogelman, J.H. (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism, 59, 551-555.
15. Riedel, M., Wiese, A., Schurmeyer, T.H. & Brabant, G. (1993) Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Experimental Clinical Endocrinology, 101, 106-111.
16. Urban, M.D., Lee, P.A., Gutai, J.P. & Migeon, C.J. (1980) Androgens in pubertal males with Addison's disease. Journal of Clinical Endocrinology and Metabolism, 51, 925-929.
17. van Vollenhoven, R.F., Engleman, E.G. & McGuire, J.L. (1994) An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum, 37, 1305-1310.
18. van Vollenhoven, R.F., Morabito, L.M., Engleman, E.G. & McGuire, J.L. (1998) Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. Journal of Rheumatology, 25, 285-289.
19. Winqvist, O., Karlsson, F.A. & Kämpe, O. (1992) 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease [see comments]. Lancet, 339, 1559-1562.
20. Yen, S.S., Morales, A.J. & Khorram, O. (1995) Replacement of DHEA in aging men and women. Potential remedial effects. Annals of the New York Academy of Science, 774, 128-142.
21. Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E.E. & Schaison, G. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Journal of Clinical Endocrinology and Metabolism, 82, 2578-2585.